Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it? Leukemia 2014 Nov;28(11):2267-70
Date
07/17/2014Pubmed ID
25027516DOI
10.1038/leu.2014.220Scopus ID
2-s2.0-84922334216 (requires institutional sign-in at Scopus site) 22 CitationsAuthor List
Barosi G, Zhang MJ, Gale RPAuthor
Mei-Jie Zhang PhD Professor in the Institute for Health and Equity department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Follow-Up StudiesHumans
Janus Kinases
Myeloproliferative Disorders
Nitriles
Pyrazoles
Pyrimidines
Randomized Controlled Trials as Topic
Survival Rate
